Tumienė Birutė, Juozapavičiūtė Augutė, Andriukaitis Vytenis
Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, M. K. Ciurlionio str. 21, Vilnius LT-03101, Lithuania.
Vilnius University Hospital Santaros Klinikos, Rare Diseases Coordination Center, Santariskiu str. 2, Vilnius LT-08661, Lithuania.
Lancet Reg Health Eur. 2023 Dec 11;37:100783. doi: 10.1016/j.lanepe.2023.100783. eCollection 2024 Feb.
Despite general advancements in population health indicators and universal health coverage, people living with rare diseases and their families still experience considerable unmet needs, including prolonged diagnostic journeys, limited treatment options, and a huge psychosocial burden due to the lack of coordinated, integrated care. Attainment of universal health coverage for rare diseases is dependent on fundamentally different health determinants and demands for different solutions. This involves consolidating expertise through Centers of Excellence, establishing efficient care pathways, fostering extensive collaboration at European and global levels in research and healthcare, and putting patients at the center of care. Furthermore, development of specific indicators and coding systems is crucial for monitoring progress. Only in this way Europe can strive towards a future where people living with rare diseases receive the same level of equitable, safe, high-quality healthcare as other members of the society, in alignment with the overarching goal of leaving no one behind.
尽管在人口健康指标和全民健康覆盖方面取得了总体进展,但罕见病患者及其家庭仍面临大量未满足的需求,包括诊断过程漫长、治疗选择有限,以及由于缺乏协调、综合的护理而承受巨大的社会心理负担。实现罕见病的全民健康覆盖取决于根本不同的健康决定因素,并需要不同的解决方案。这包括通过卓越中心整合专业知识、建立高效的护理途径、在欧洲和全球层面促进研究与医疗保健方面的广泛合作,以及将患者置于护理的中心。此外,制定具体指标和编码系统对于监测进展至关重要。只有这样,欧洲才能朝着一个未来努力,即罕见病患者能获得与社会其他成员同等水平的公平、安全、高质量医疗保健,这与不让任何人掉队的总体目标相一致。